SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-054525
Filing Date
2005-10-31
Accepted
2005-10-31 19:57:04
Documents
2
Period of Report
2005-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 44503
2 POA DOCUMENT poa.txt EX-24.4_106305 5637
  Complete submission text file 0001209191-05-054525.txt   52103
Mailing Address C/O KELSO & CO 350 PARK AVENUE 24TH FLOOR NEW YORK NY 10022
Business Address C/O KELSO & CO 350 PARK AVENUE 24TH FLOOR NEW YORK NY 10022 2127513939
KELSO PARTNERS V L P (Reporting) CIK: 0001045750 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-15989 | Film No.: 051167674

Mailing Address 100 ENDO BOULEVARD CHADDS FORD PA 19317
Business Address 100 ENDO BOULEVARD CHADDS FORD PA 19317 6105589800
ENDO PHARMACEUTICALS HOLDINGS INC (Issuer) CIK: 0001100962 (see all company filings)

IRS No.: 134022871 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations